Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6105927rdf:typepubmed:Citationlld:pubmed
pubmed-article:6105927lifeskim:mentionsumls-concept:C0020663lld:lifeskim
pubmed-article:6105927lifeskim:mentionsumls-concept:C0074854lld:lifeskim
pubmed-article:6105927lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6105927lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:6105927lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:6105927pubmed:issue21lld:pubmed
pubmed-article:6105927pubmed:dateCreated1980-11-20lld:pubmed
pubmed-article:6105927pubmed:abstractTextWe have isolated from extracts of ovine hypothalamus two molecules characterized as somatostatin-28 and somatostatin-4-28 (referred to as somatostatin-25). They were reproduced by synthesis. In equimolar ratios and depending upon the experimental conditions, synthetic somatostatin-28 and somatostatin-25 are 3 to 14 times more potent than somatostatin-14 to inhibit the basal in vitro secretion of growth hormone. These results suggest that somatostatin-14 as originally isolated, is a biologically active fragment of a larger molecule of greater specific activity, rather than somatostatin-28 being a precursor of the tetradecapeptide.lld:pubmed
pubmed-article:6105927pubmed:languagefrelld:pubmed
pubmed-article:6105927pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6105927pubmed:citationSubsetIMlld:pubmed
pubmed-article:6105927pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6105927pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6105927pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6105927pubmed:statusMEDLINElld:pubmed
pubmed-article:6105927pubmed:monthJunlld:pubmed
pubmed-article:6105927pubmed:issn0567-655Xlld:pubmed
pubmed-article:6105927pubmed:authorpubmed-author:BrazeauPPlld:pubmed
pubmed-article:6105927pubmed:authorpubmed-author:GuilleminRRlld:pubmed
pubmed-article:6105927pubmed:authorpubmed-author:LindKKlld:pubmed
pubmed-article:6105927pubmed:authorpubmed-author:BohlenPPlld:pubmed
pubmed-article:6105927pubmed:authorpubmed-author:BenoîtRRlld:pubmed
pubmed-article:6105927pubmed:authorpubmed-author:EschFFlld:pubmed
pubmed-article:6105927pubmed:issnTypePrintlld:pubmed
pubmed-article:6105927pubmed:day9lld:pubmed
pubmed-article:6105927pubmed:volume290lld:pubmed
pubmed-article:6105927pubmed:ownerNLMlld:pubmed
pubmed-article:6105927pubmed:authorsCompleteYlld:pubmed
pubmed-article:6105927pubmed:pagination1369-71lld:pubmed
pubmed-article:6105927pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:meshHeadingpubmed-meshheading:6105927-...lld:pubmed
pubmed-article:6105927pubmed:year1980lld:pubmed
pubmed-article:6105927pubmed:articleTitle[High biological activity of the synthetic counterparts of hypothalamic somatostatin-28 and somatostatin-25].lld:pubmed
pubmed-article:6105927pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6105927pubmed:publicationTypeEnglish Abstractlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6105927lld:pubmed